Source: ALL
Gene Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
Entrez Id: 1081
Gene Symbol: CGA
CGA 		0.300 Therapeutic group CTD_human The involvement of hypophyseal-gonadal and hypophyseal-adrenal axes in arsenic-mediated ovarian and uterine toxicity: modulation by hCG. 20146381 2010
Entrez Id: 1588
Gene Symbol: CYP19A1
CYP19A1 		0.300 Biomarker group CTD_human Dietary bisphenol A prevents ovarian degeneration and bone loss in female mice lacking the aromatase gene (Cyp19 ). 11985600 2002
Entrez Id: 197135
Gene Symbol: PATL2
PATL2 		0.200 Biomarker group MGD
Entrez Id: 268
Gene Symbol: AMH
AMH 		0.010 Biomarker group BEFREE Recent studies have highlighted the role of anti-Müllerian hormone (AMH) in numerous ovarian disorders. 30584404 2018
Entrez Id: 407018
Gene Symbol: MIR27A
MIR27A 		0.010 Biomarker group BEFREE MicroRNA-27a-3p affects estradiol and androgen imbalance by targeting Creb1 in the granulosa cells in mouse polycytic ovary syndrome model. 29089199 2017
Entrez Id: 1385
Gene Symbol: CREB1
CREB1 		0.010 Biomarker group BEFREE MicroRNA-27a-3p affects estradiol and androgen imbalance by targeting Creb1 in the granulosa cells in mouse polycytic ovary syndrome model. 29089199 2017
Entrez Id: 29126
Gene Symbol: CD274
CD274 		0.010 AlteredExpression group BEFREE Here, in ovarian cancer, PD-L1 is selectively overexpressed on some TAM compared that of benign ovarian disease. 26541760 2016
Entrez Id: 55591
Gene Symbol: VEZT
VEZT 		0.010 GeneticVariation group BEFREE SNP rs10859871 near the vezatin (VEZT) gene was found to be significantly associated with endometriosis in general while SNPs rs17694933 and rs4141819 were associated with Stage III/IV and ovarian disease, respectively. 25678572 2015
Entrez Id: 2661
Gene Symbol: GDF9
GDF9 		0.010 AlteredExpression group BEFREE Aberrant GDF9 expression and activation are associated with common human ovarian disorders. 24438375 2014
Entrez Id: 2833
Gene Symbol: CXCR3
CXCR3 		0.010 GeneticVariation group BEFREE Currently, little is known about the roles of CXCR3 variants in these ovarian diseases. 21684584 2011
Entrez Id: 10018
Gene Symbol: BCL2L11
BCL2L11 		0.010 GeneticVariation group BEFREE Principal component analysis, supervised clustering, linear discrimination analysis, and 25 rounds of 5-fold cross-validation were used to determine informative genes and assess the sensitivity and specificity of differentiating between OvCa vs. healthy control (HC), benign ovarian disease (mostly serous cystadenoma, BOD) vs. HC, and OvCa vs. BOD samples. 21056906 2011
Entrez Id: 4070
Gene Symbol: TACSTD2
TACSTD2 		0.010 Biomarker group BEFREE We evaluated the expression of human trophoblast cell-surface marker (Trop-2) and the potential of hRS7, a humanized monoclonal anti-Trop-2 antibody, as a therapeutic agent against chemotherapy-resistant ovarian disease. 21453957 2011
Entrez Id: 8988
Gene Symbol: HSPB3
HSPB3 		0.010 Biomarker group BEFREE Immunohistochemical staining for HSP27 in human ovarian cancer specimens showed HSP27 was associated with aggressive malignant ovarian disease. 19930842 2010
Entrez Id: 3316
Gene Symbol: HSPB2
HSPB2 		0.010 Biomarker group BEFREE Immunohistochemical staining for HSP27 in human ovarian cancer specimens showed HSP27 was associated with aggressive malignant ovarian disease. 19930842 2010
Entrez Id: 3315
Gene Symbol: HSPB1
HSPB1 		0.010 Biomarker group BEFREE Immunohistochemical staining for HSP27 in human ovarian cancer specimens showed HSP27 was associated with aggressive malignant ovarian disease. 19930842 2010
Entrez Id: 152831
Gene Symbol: KLB
KLB 		0.010 AlteredExpression group LHGDN Klotho expression in epithelial ovarian cancer and its association with insulin-like growth factors and disease progression. 18259951 2008
Entrez Id: 1508
Gene Symbol: CTSB
CTSB 		0.010 AlteredExpression group LHGDN The role of cathepsin B and cystatin C in the mechanisms of invasion by ovarian cancer. 14984956 2004